Y. Kim

发表

A Machine Learning-Based Identification of Genes Affecting the Pharmacokinetics of Tacrolimus Using the DMETTM Plus Platform

Jeong-An Gim, Hyun A Lee, Kyeong-Ryoon Lee, 2020, International journal of molecular sciences.

A Machine Learning-Based Identiﬁcation of Genes A ﬀ ecting the Pharmacokinetics of Tacrolimus Using the DMET TM Plus Platform

Jeong-An Gim, Hyun A Lee, Kyeong-Ryoon Lee, 2020 .

No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects

J. Hwang, Yu Kyong Kim, M. Park, 2021, Drug design, development and therapy.

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects

K. Yu, I. Jang, Jaeseong Oh, 2023, Clinical and translational science.

New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients

Howard Lee, Anhye Kim, Yu Kyong Kim, 2017, Drug design, development and therapy.

Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject

Yujin Lee, S. Ji, Sae Im Jeong, 2022, Translational and clinical pharmacology.

Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers

K. Yu, Yong-Il Kim, Yu Kyong Kim, 2020, Translational and clinical pharmacology.

The necessary conduct: Exploratory multiregional clinical trials in East Asia

K. Yu, I. Jang, Inseung Jeon, 2021, Clinical and translational science.

Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects

K. Yu, I. Jang, SeungHwan Lee, 2018, Drug design, development and therapy.

Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects

Eunwoo Kim, Joo-Youn Cho, K. Yu, 2018, European Journal of Clinical Pharmacology.

A comparative pharmacokinetic and tolerability analysis of the novel orotic acid salt form of tenofovir disoproxil and the fumaric acid salt form in healthy subjects

K. Yu, SeungHwan Lee, Yu Kyong Kim, 2017, Drug design, development and therapy.

Population Pharmacokinetic Study of Prophylactic Fluconazole in Preterm Infants for Prevention of Invasive Candidiasis

K. Yu, S. Yoon, S. Shin, 2019, Antimicrobial Agents and Chemotherapy.

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication

K. Yu, Yu Kyong Kim, Hyewon Chung, 2021, British journal of clinical pharmacology.

Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects.

I. Jang, SeungHwan Lee, Jina Jung, 2023, Drug design, development and therapy.

Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese

K. Yu, I. Jang, SeungHwan Lee, 2021, Clinical and translational science.